InvestorsObserver
×
News Home

Can Kymera Therapeutics Inc (KYMR) Stock Rise to the Top of Healthcare Sector Friday?

Friday, March 15, 2024 11:56 AM | InvestorsObserver Analysts

Mentioned in this article

Can Kymera Therapeutics Inc (KYMR) Stock Rise to the Top of Healthcare Sector Friday?

The 60 rating InvestorsObserver gives to Kymera Therapeutics Inc (KYMR) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 72 percent of stocks in the Healthcare sector, KYMR’s 60 overall rating means the stock scores better than 60 of all stocks.

Overall Score - 60
KYMR has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on KYMR!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Kymera Therapeutics Inc Stock Today?

Kymera Therapeutics Inc (KYMR) stock is up 2.47% while the S&P 500 is lower by -0.64% as of 11:51 AM on Friday, Mar 15. KYMR has risen $0.97 from the previous closing price of $39.51 on volume of 172,490 shares. Over the past year the S&P 500 has risen 29.22% while KYMR has risen 30.20%. KYMR lost -$2.52 per share the over the last 12 months. Click Here to get the full Stock Report for Kymera Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App